earnings digest health care medtronic inc medtronic inc saw improved sales across a host of product areas which helped to offset weakness among implantable cardiac defibrillators the companys most closely watched product sales of the devices or icds totaled &# million in the third quarter ended jan down from the year ago period a slide in domestic icd sales offset strong international gains icds are small implanted devices that shock hearts from dangerously rapid and potentially fatal beating and represent nearly a quarter of medtronics sales the minneapolis companys earnings report was anticipated to be a barometer of the icd market where medtronic is the largest player ahead of boston scientific corp and st jude medical inc the market has recently shown modest signs of improvement after a very rough 
